Source: Marketing Authorisation Holder Revision Year: 2021 Publisher: Manufacturer tablets: UCB Farchim S.A., Z.I. de Planchy, 10 Chemin de Croix Blanche, CH-1630 Bulle, Switzerland Packager: Aesica Pharmaceuticals S.r.l., Via Praglia 15, I 10044 Pianezza, Italy
Zyrtec-D.
| Pharmaceutical Form |
|---|
|
Prolonged release tablet is white to off-white, round biconvex film-coated tablet having a circular logo on one side. |
Each tablet contains 5 mg cetirizine dihydrochloride in an immediate release form and 120 mg pseudoephedrine hydrochloride in a prolonged-release form.
| Active Ingredient | Description | |
|---|---|---|
| Cetirizine |
Cetirizine, a human metabolite of hydroxyzine, is a potent and selective antagonist of peripheral H1-receptors. In vitro receptor binding studies have shown no measurable affinity for other than Η1-receptors. |
|
| Pseudoephedrine |
Pseudoephedrine is a sympathomimetic agent with direct and indirect effects on adrenergic receptors. It has alpha and beta adrenergic activity and some stimulant effect on the central nervous system. The sympathomimetic effect of pseudoephedrine produces vasoconstriction which in turn relieves nasal congestion. |
| List of Excipients |
|---|
|
Hypromellose |
The tablets are packed in PVC-Aclar Rx 160/Aluminium foil blisters or child resistant OPA/Alu/PVCAlu/Paper blisters placed in a cardboard box containing 10 and 50 tablets.
Manufacturer tablets: UCB Farchim S.A., Z.I. de Planchy, 10 Chemin de Croix Blanche, CH-1630 Bulle, Switzerland
Packager: Aesica Pharmaceuticals S.r.l., Via Praglia 15, I – 10044 Pianezza, Italy
| Drug | Countries | |
|---|---|---|
| ZYRTEC-D | Cyprus, Ecuador, Hong Kong, Singapore |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
